Clinical Trials
At AASLD 2020 virtual liver conference, Dr. Gideon Hirschfield presented promising Phase 3 results for Seladelpar a treatment for patients with PBC. Positive outcomes included:
November 23, 2020
No Comments
Blog
Category: PBC News
- Home
- Category: PBC News
Clinical Trials
There is a new clinical trial aimed at PBC pruritus. While the study is currently in New Zealand and Australia, there are plans to expand
November 23, 2020
No Comments
Clinical Trials
Linerixibat (GSK2330672), a drug that is being developed for PBC patients who experience itchiness, has recently published Phase 2b results. This is promising news for
November 13, 2020
No Comments
PBC News
Obeticholic Acid was approved in Canada in May 2017, this study describes its effectiveness in two Canadian centers. Read more.
October 24, 2020
No Comments
On November 25, 2019, CymaBay halted all clinical trials of seladelpar after atypical histologic findings with no clinical or laboratory correlates were identified at the
July 30, 2020
No Comments
PBC News
This year the PBC Network created a 36 page booklet “PBC – Living With Your Diagnosis” . The Canadian PBC Society participated in the final
January 9, 2020
No Comments
Seladelpar, a drug developed for PBC patients, has shown positive results in Phase 2 studies- normalizing ALP levels, while not associated with itching. In
November 25, 2019
No Comments
Clinical Trials
Elafibranor, phase 2 trial has shown positive preliminary results in helping those PBC patients who do not respond to UDCA (Urso). In addition, Elafibranor has
November 8, 2019
No Comments
PBC News
University of Calgary PBC researchers tested the anti-depressant mirtazapine on mice and found promising results. Their report concluded that mirtazapine may represent a novel therapeutic
November 7, 2019
No Comments
Clinical Trials
PBC patients across Canada can get involved in a number of Clinical Trials. Learn more about all of the clinical trials now underway and read
September 24, 2019
No Comments